Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe

Published: 2026-05-11 11:51:22 ET EOLS

Published on 05/11/2026 at 11:51 am EDT

Evolus, Inc. announced that the commercial launch of Estyme (pronounced ?esteem?), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company?s entry into the international dermal filler market. The Estyme collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme Smooth and Estyme Form, which are currently marketed in the United States under the brand Evolysse, along with the debut of two products including Estyme Lips and the flagship product in the line, Estyme Sculpt, which is expecting U.S. FDA approval later this year.

Developed for restoring mid-face volume, Estyme Sculpt addresses one of the most in-demand treatment areas in aesthetics. Designed by Symatese, the innovative Cold-X technology helps preserve the natural structure of the HA molecule, providing long-lasting, natural-looking results.